CT Bhalla评分与COPD合并支气管扩张患者肺功能的相关性

doi:10.3969/j.issn.1671-7171.2023.07.017

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1227 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨慢性阻塞性肺疾病(COPD)合并支气管扩张患者计算机断层扫描(CT) Bhalla评分与肺功能的相关性。【方法】回顾性分析2021年1月至2022年1月本院收治的100例COPD患者的临床资料,根据是否合并支气管扩张分为单纯COPD组(COPD组,n=65)和合并支气管扩张组(支扩组,n=35)。比较两组患者CT Bhalla评分、肺功能指标[第一秒用力呼出气容积/用力肺活量比值(FEV1/FVC)、最大呼气流速(PEF)、6 min步行距离(6MWT)]、白介素-6(IL-6)、白介素-33(IL-3)、C反应蛋白(CRP)、肿瘤坏死因子α(TNF-α)水平;采用受试者工作特征(ROC)曲线分析CT Bhalla评分、肺功能指标、IL-6、IL-33、CRP、TNF-α对COPD合并支气管扩张的预测价值;采用Spearman秩相关分析肺功能指标、IL-6、IL-33、CRP、TNF-α水平与CT Bhalla评分的相关性。【结果】支扩组CT Bhalla评分、IL-6、IL-33、CPR和TNF-α水平显著高于COPD组,6MWT、FEV1/FVC、PEF低于COPD组(P<0.05);ROC曲线分析证实:CT Bhalla评分、6MWT、FEV1/FVC、PEF、IL-6、IL-33、CRP、TNF-α均可用于COPD合并支气管扩张的预测,曲线下面积分别为0.967、0.906、0.718、0.783、0.582、0.825、0.738、0.745;CT Bhalla评分与6MWT、FEV1/FVC、PEF呈负相关(P<0.05),与IL-6、IL-33、CPR和TNF-α呈正相关(P<0.05)。【结论】CT Bhalla评分在COPD合并支气管扩张患者中显著升高,且与肺功能、IL-6、IL-33、CPR和TNF-α水平密切相关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	范融
	王丽雯

关键词 ：肺疾病, 慢性阻塞性/并发症, 支气管扩张症/并发症, 体层摄影术, X线计算机, 呼吸功能试验

Abstract：【Objective】To investigate the correlation between Bhalla score of computed tomography (CT) and pulmonary function in patients with chronic obstructive pulmonary disease (COPD) and Bronchiectasis. 【Methods】The clinical data of 100 patients with COPD admitted to our hospital from January 2021 to January 2022 were retrospectively analyzed. According to whether Bronchiectasis was combined or not, they were divided into a simple COPD group (COPD group, n=65) and a combined Bronchiectasis group (bronchiectasis group, n=35). CT Bhalla scores, lung function indexes (FEV1/FVC, PEF, 6MWT), interleukin-6 (IL-6), interleukin-33 (IL-3), C-reactive protein (CRP), and tumor necrosis factor-α(TNF-α) levels were compared between the two groups; The predictive value of CT Bhalla score, pulmonary function index, IL-6, IL-33, CRP, TNF-α in COPD with Bronchiectasis was analyzed by receiver operating characteristic (ROC) curve; Spearman rank correlation analysis was used to investigate the correlation between lung function indicators, IL-6, IL-33, CRP, TNF-α levels, and CT Bhalla score.【Results】The CT Bhalla score, IL-6, IL-33, CPR and TNF-α levels in the Bronchiectasis group were significantly higher than those in the COPD group, while 6MWT, FEV1/FVC, PEF were lower than those in the COPD group (P<0.05); Receiver operating characteristic analysis confirmed that CT Bhalla score, 6MWT, FEV1/FVC, PEF, IL-6, IL-33, CRP, TNF-α can be used to predict COPD with Bronchiectasis, and the area under the curve was 0.967, 0.906, 0.718, 0.783, 0.582, 0.825, 0.738, 0.745 respectively; The CT Bhalla score was negatively correlated with 6MWT, FEV1/FVC, and PEF (P<0.05), and positively correlated with IL-6, IL-33, CPR, and TNF-α (P<0.05). 【Conclusion】CT Bhalla score is significantly increased in COPD patients with Bronchiectasis, and is closely related to lung function, IL-6, IL-33, CPR and TNF-α levels.

Key words： Pulmonary Disease, Chronic Obstructive/CO Bronchiectasis/CO Tomography, X-Ray Computed Respiratory Function Tests

收稿日期: 2022-12-28

中图分类号:

R563

通讯作者: *E-mail: 689831426@qq.com

引用本文:

范融, 王丽雯. CT Bhalla评分与COPD合并支气管扩张患者肺功能的相关性[J]. 医学临床研究, 2023, 40(7): 1021-1024.
FAN Rong, WANG Li-wen. Correlation between CT Bhalla Score and Pulmonary Function in COPD Patients with Bronchiectasis. JOURNAL OF CLINICAL RESEARCH, 2023, 40(7): 1021-1024.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.07.017 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I7/1021

[1] 张力,刘璇,陆沈栋,等. α1-抗胰蛋白酶在稳定期慢性阻塞性肺疾病合并支气管扩张患者血清中的表达及其临床意义[J].医学临床研究,2020,37(2):193-195.
[2] 刘斌,周瑞清,邢青峰. 胸腺肽对COPD合并支气管扩张患者免疫功能的影响[J].中国老年学杂志,2021,41(11):2307-2311.
[3] 邓爱兵,宋健,王静,等. 肺CT联合降钙素原、C反应蛋白检测对COPDⅡ型呼吸衰竭疗效、预后评估的临床价值[J].临床和实验医学杂志,2021,20(2):161-165.
[4] 周洁,翁婷,高蔚. CT Bhalla评分评估支气管扩张患者预后的价值[J].中国医药导报,2021,18(5):121-124.
[5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460.
[6] 成人支气管扩张症诊治专家共识编写组. 成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志,2012,35(7):485-492.
[7] 曹洪丽,于红,石曼欣妤,等. 支气管肺泡灌洗术联合局部应用敏感抗菌药物对COPD合并支气管扩张患者血气分析、炎症因子及肺功能的影响[J].国际检验医学杂志,2022,43(1):90-93.
[8] 吴玲,梁宗安. 支气管扩张症-慢性阻塞性肺疾病重叠综合征临床特点分析[J].国际呼吸杂志,2020,40(2):87-93.
[9] 蒲豆豆,马军超,于勇,等. 支气管扩张程度的CT定量评估:与人工方法的对照研究[J].放射学实践,2022,37(8):982-986.
[10] 周洁,翁婷,高蔚. CT Bhalla评分评估支气管扩张患者预后的价值[J].中国医药导报,2021,18(5):121-124.
[11] 邹外龙,闫磊,张鑫,等. 支气管扩张症合并慢性阻塞性肺疾病急性加重患者住院死亡的相关因素[J].中华老年多器官疾病杂志,2021,20(8):590-594.
[12] 祁晶,付秀华,王立红,等. 慢性阻塞性肺疾病合并支气管扩张急性加重期肺功能异常的风险因素分析[J].内蒙古医科大学学报,2021,43(4):391-395.
[13] 王萌萌,於海洋,孙雨晴,等. 慢性阻塞性肺疾病患者IL-6、IL-8、TNF-α水平与支气管黏膜自噬的相关性分析[J].临床肺科杂志,2021,26(7):997-1003.
[14] KIM R Y, OLIVER B G, WARK P A B, et al. COPD exacerbations:targeting IL-33 as a new therapy[J].Lancet Respir Med,2021,9(11):1213-1214.
[15] 孙智娜,何秀琴,拉毛卓玛,等.CT Bhalla评分与COPD合并支气管扩张患者肺功能、血气、炎症因子及气道阻力的关系[J].山东医药,2019,59(2):52-54.